Translation Elongation Factor 2 Is Part of the Target for a New Family of Antifungals

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 42; no. 10; pp. 2694 - 2699
Main Authors CAPA, L, MENDOZA, A, LAVANDERA, J. L, GOMEZ DE LAS HERAS, F, GARCIA-BUSTOS, J. F
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.10.1998
Subjects
Amino Acid Sequence
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal Agents
Antifungal Agents - pharmacology
Binding Sites
Biological and medical sciences
Drug Resistance, Microbial
Indenes
Mechanisms of Action: Physiological Effects
Medical sciences
Molecular Sequence Data
Mutation
Peptide Elongation Factor 2
Peptide Elongation Factors
Peptide Elongation Factors - chemistry
Peptide Elongation Factors - drug effects
Peptide Elongation Factors - genetics
Pharmacology. Drug treatments
Saccharomyces cerevisiae
Resistance
Antifungal agent
Microorganism growth
Three dimensional structure
Elongation factor EF2
Translating
Complementation
Mutation
In vitro
Modeling
Biological activity
Online AccessGet full text

Cover

More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Mailing address: Research Department, Glaxo Wellcome, S.A., Severo Ochoa 2, 28760 Tres Cantos, Spain. Phone: 34-91-807-0606. Fax: 34-91-807-0550. E-mail: jfg32652@glaxowellcome.co.uk.
ISSN:0066-4804
1098-6596
DOI:10.1128/aac.42.10.2694